pipette
ESEspañol

Old lineages, new threat: the re-emergence of pneumococcal serotype 14 in adults in Catalonia, Spain (2023-2025).

A. Gonzalez-Diaz, S. Broner, S. Calvo-Silveria, I. Grau, M. D. Quesada, A. Belles, E. del Corral, E. Pico-Plana, E. Clapes, B. Vinado, D. Berbel, M. A. Llopis, M. A. Dominguez, S. Marti, J. Camara, P. Ciruela, C. Ardanuy

PreprintReal-world use

In the authors' words

Introduction: The introduction of pneumococcal conjugate vaccines resulted in a decline in invasive pneumococcal disease (IPD). Nevertheless, recent studies report a re-emergence of vaccine-included serotypes. Aim: To describe the recent re-emergence of serotype 14 IPD among adults in Catalonia and to investigate the factors underlying its resurgence. Methods: We analysed two collections of adult IPD isolates: a historical series from Hospital Universitari de Bellvitge (1996-2025) and a multicentre series from seven tertiary hospitals in Catalonia (2023-2025). Isolates were serotyped (Quellung) and genotyped by PFGE/MLST (1996-2022) or Illumina sequencing (2023-2025). Clinical data were retrospectively collected. Results: The historical series showed that, after peaking in 2009, serotype 14 frequency gradually declined, with only -4 cases reported annually between 2016 and 2020. However, the number of serotype 14 isolates increased again in 2025, reaching 11.0% of all isolates at HUB and 10.8% across Catalonia. Genomic data showed that this increase involved multiple previously circulating lineages (GPSC6, GPSC18, GPSC16 and GPSC39), with no dominant clone. Analysis of the capsular locus revealed substantial genetic diversity, with no association between capsular variants and either lineage or year of isolation. A substantial proportion of patients (56.3%) had multiple comorbidities and only 18.8% were appropriately vaccinated. Discussion: The re-emergence of serotype 14 was not associated with a novel lineage or capsular variant. Instead, it may reflect a combination of post-pandemic transmission changes, higher-valency paediatric vaccines, and natural fluctuations in serotype circulation. These findings highlight the limits of herd protection and underscore the need to strengthen adult vaccination, particularly among at-risk populations.

Main resultThe abstract does not state a limitation.

Appeared: Wednesday, November 18. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.16.26367621